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Diagnostic performance of enzyme-linked
immunospot assay and whole-blood interferon-g
assay for the diagnosis of extrapulmonary
tuberculosisSir,
Recently, Weng et al1 reported the clinical manifestations of
38 non-HIV-infected patients with spinal tuberculosis (TB). In
that study, they showed that the median duration of symp-
toms before diagnosis was 60 days (range, 3e720 days). Chou
et al2 reported a similar duration of symptoms before diag-
nosis in 34 adult patients with abdominal TB (median, 58
days; range, 10e175 days). Both studies indicated that the
diagnosis of extrapulmonary TB was not easy to establish
because of its nonspecific clinical presentation. The confir-
mation of diagnosis usually requires mycobacterial culture of
biopsied tissue or relevant specimens; however, mycobac-
terial culture confirmation testing is time consuming and
often takes weeks to complete. Therefore, novel diagnostic
modalities are urgently needed. Immune-based blood assays,
which require only a blood sample and take less than 48 hours
to complete, may serve as alternative diagnostic tools.
Recently, interferon-g (IFN-g) release assays (IGRAs) have
been developed for the screening of TB infection. These
immunodiagnostic tests, namely, the whole-blood IFN-g
enzyme-linked immunosorbent assay (QuantiFERON-TBGold;
Cellestis Ltd, Victoria, Australia) and the enzyme-linked
immunospot assay (T-SPOT.TB; Oxford Immunotec, Oxford-
shire, UK), can quantitatively measure IFN-g production by
lymphocytes specific toMycobacterium tuberculosis-specific
immunodominant antigens (early secretory antigenic target
6 and culture filtrate protein 10) that are encoded by the RD1
region of the pathogen. Another commercially available
IGRA, namely, the QuantiFERON-TB Gold in-tube assay (QFT-
GIT; Cellestis Ltd, Carnegie, Australia), is able to measure
IFN-g production specific to the immunodominant antigens
TB7.7, early secretory antigenic target 6, and culture filtrate
protein 10. Several studies have demonstrated that IGRAs
may be useful tools in the diagnosis of extrapulmonary TB3,4;1684-1182/$36 Copyright ª 2011, Taiwan Society of Microbiology. Publ
doi:10.1016/j.jmii.2011.07.002however, few studies have compared the effectiveness of
the QFT-GIT with that of the T-SPOT.TB assay in diagnosing
active TB in patients clinically suspected of having extrap-
ulmonary TB. Therefore, we performed this study to assess
the diagnostic value of the QFT-GIT and T-SPOT.TB assays in
clinically suspected cases of extrapulmonary TB.
This study was conducted at the National Taiwan
University Hospital, a 2,500-bed medical center. All adult
patients with suspected extrapulmonary TB were prospec-
tively enrolled from October 2009 to October 2010. The
patients were categorized as having confirmed TB if
M tuberculosis was recovered from a clinical specimen; as
having probable TB if histological findings of a biopsy
specimen were consistent with a diagnosis of TB infection
(granulomatous inflammation and/or caseous necrosis) or if
the symptoms and signs of active TB were present in
a patient who responded clinically and radiologically to
a full course of anti-TB treatment; or as not having TB if
another diagnosis was made or if there was clinical
improvement without anti-TB therapy. All of the laboratory
tests, including identification of M tuberculosis, T-SPOT.TB,
and QFT-GIT, were performed as previously described.5
A total of 33 non-HIV-infected patients with suspected
extrapulmonary TB were recruited during the study period
(Table 1). Among these patients, 22 (66.7%) had confirmed
TB, five (15.2%) had probable TB, and the remaining six
(18.2%) did not have TB. Positive T-SPOT.TB results were
detected in 20 (90.9%) of the 22 patients with confirmed TB
and in four of the five patients with probable TB. We found
that the T-SPOT.TB assay had an overall (confirmed and
probable TB) sensitivity of 88.9% [95% confidence interval
(CI), 0.64e0.92] and a specificity of 50.0% (95% CI,
0.14e0.86). Positive QFT-GIT results were detected in 15
(68.2%) of the 22 patients with confirmed TB and in three of
the five patients with probable TB. After excluding oneished by Elsevier Taiwan LLC. All rights reserved.
Table 1 Summary of demographic and clinical characteristics of 33 patients with suspected extrapulmonary tuberculosis
Variables No. (%) of patients with
extrapulmonary tuberculosis (nZ 27)
No. (%) of patients without
extrapulmonary tuberculosis (nZ 6)
Mean age, y (range) 56.4 (19e80) 70.6 (47e90)
No. of patients (male/female) 15/12 4/2
Underlying condition
Diabetes mellitus 9 (33.3) 2 (33.3)
Malignancy 4 (14.8) 4 (66.7)
Chronic kidney disease 2 (7.4) 0 (0.0)
No underlying disease 5 (18.5) 2 (33.3)
Suspected infection sites
Genitourinary 8 (29.6) 0 (0.0)
Bone/joint 5 (18.5) 0 (0.0)
Lymph node 5 (18.5) 2 (33.3)
Pleura 3 (11.1) 1 (16.7)
Central nervous system 2 (7.4) 2 (33.3)
Abdomen 3 (11.1) 0 (0.0)
Pericardium 2 (2.2) 0 (0.0)
Cutaneous 1 (3.7) 0 (0.0)
Positive T-SPOT.TB assay 24 (88.9) 3 (50.0)
Positive QFT-GIT assay 18 (66.7) 3 (50.0)
QFT-GITZQuantiFERON-TB Gold in-tube.
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that the QFT-GIT had an overall (confirmed and probable
TB) sensitivity of 69.2% (95% CI, 0.48e0.85) and a specificity
of 50.0% (95% CI, 0.14e0.86).
In this study, we found that the T-SPOT.TB assay was
more sensitive than the QFT-GIT in diagnosing extrap-
ulmonary TB, especially in culture-confirmed TB cases. This
suggests that the T-SPOT.TB assay is a helpful adjunct
diagnostic tool in patients with suspected extrapulmonary
TB. Both assays, however, have relatively poor specificity,
indicating that they are not able to discriminate between
active TB and latent TB infection.
There are two important limitations of this study. First,
the tuberculin skin test is not routinely performed in patients
with suspected TB in Taiwan, largely because of the nation-
wide Bacille Calmette-Gue´rin vaccination program. There-
fore, we could not compare the performances of tuberculin
skin test and IGRA in diagnosing exptrapulmonary TB. Second,
although the specificity of IGRA is dependent on the local
prevalence of latent TB infection, there is little to no infor-
mation about the prevalence of latent infection in Taiwan.
In conclusion, the T-SPOT.TB test had a higher sensitivity
than the QFT-GIT assay for diagnosing extrapulmonary TB.
Large-scale studies are needed to evaluate the diagnostic
usefulness of IGRA.
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